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The introduction of a technique that purports to
increase our understanding of a particular disorder
leads inevitably to a reassessment of the existing body
of knowledge about that disorder. Sometimes a
re-evaluation of the methods of the discipline may occur.
When one such innovation, the dexamethasone
suppression test (DST) , \¡ras introduced into clinical
psychiatry at the Royal Adelaide Hospital, a study was
conducted into its effects on d,iagnosis and treatment of
depression. The results of this study, which are detailed
in chapter Three of this dissertation, indicate that
considerable changes in management (and also perhaps in
thinking about clinical problems) occurred concurrently
with the introduction of the DST. Specifically, the study
showed increases in the diagnosis of biological depression
and treatment with antidepressants. There htas no
association between DST results and particular management
plans. There was, however, a very strong association
between requesting the DST and subsequent management with
antidepressants .
These results Ied to a re-evaluation of the literature
of the development of the DST as a specific laboratory
test for melancholia. chapter Two follows Rubin and
Mandell's hypothesis that elevated cortisol levels vrere
a specific concomitant of depression, through nearly 20
years of research. In particular, the rapid increase in
the literature on the DST in the early '80s is reviewed.
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SUMMARY (continued)
The chapter ends with a discussion of Some very recent
cautionary articles about the application of the DST to
psychiatry.
The results of the DST study led also to a
re-evaluation of one of the fundamental processes of
psychiatry and of all medicine, the process of clinical
judgment. chapter one is concerned with decision making
in psychiatry and how the process in psychiatry differs
from that in general medicine. Issues of diagnosis are
considered, along with the relevance of diagnosis to
treatment. The notion of a psychiatÈist's "set" with
respect to management is commented upon, along with the
notion of maximising utility with respect to diagnosis
and treatment.
The dissertation concludes with only conjectures
to explain the results. Studies to address these
conjectures could lead to a greater understanding, not
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CHAPTER ONE:
DECISION MAKING, DIAGNOSIS AND TREATMENT TN PSYCHIATRY:
I. Decision Mak inq ín General Medicine.
The rapid increase of information concerning the
nature of anatomical, physiological and biochemical
abnormalities occurring in particular diseases has led
inevitably to the development of the study of the
methodologies by which physicians decide whether a
disease is present and how it ís best treated. Even
with the large amounts of information about their patients'
anatomy, physiology and biochemistry which physicians
may have at their disposal, decisions about diagrnosis
and treatment are still decisions which entail the
balancing of probabilities, the exercising of cl-inical
judgment. Clinical judgment is often regarded as the
"art" of medicine, the process by which the experience
of similar previous cases is combined with the current
clinical presentation and a diagnosis and a management
plan distilted from the mixture.
There have been several attempts to explore
rationally the logic of this "intuitive" aspect of
medicine. One of the most widely studied theories for
making decisions under conditions of uncertainty, and one
which has been said to closely approximate the process of
the diagnostic process, is Bayes' theoremr . This theorem
was devised by the Rev. Thomas Bayesr ërfi IBth century
English clergyman. It provides a method to quantify the
9
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means by which new evidence is used to modify prior
judgments.
Lusted2 has applied Baysian probability theory to
medicine in general, and to diagrrostic radiology in
partÍcular.However,widerapplicationsofthisattempt
toformaliseandimprovemedicaldecisionmakinghave
been slow in arriving. An editorial3 of the New England
Journar of r,redicine in Lg75 commented that this rack of
application of decision theory to medicine may reflect a
difficulty many physicians have wíth the mathematics any
attempttosystematiseclinicaljudgmententails.It
added the caveat that any decision making theory can onry
prov.i-de decisions of simirar validity to the data supplied.
So íf, overall, the application of systematised
decision making theory to medicine has been slow, what of
iùsparticularrelevancetopsychiatry?Beforeananswer
to this question can be attempted, it is necessary to
consider the nature of diagnosis in psychiatry.
2. Psychiatric Diagnos is .
The problems of diagnosis in psychiatry are numerous'
It has been argued by szasz) that psychiatric disorders
are not diseases but expressions of "problems in living",
and therefore the process of medical diagnosis is
inappropriate when classifying these problems. Rosenhans
has argued that "unlike most medical diagnoses, which can
be validated in various ways, psychiatric diagnoses are
11
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courses. For example, individual ailments such as a pain
in the knee, a pain in the big toe and a tophus in the
ear, could be classified as a cluster of ailments commonly
occurring together the disease gout. fn psychiatry'
the description of behaviour and the recording of the
experiences of patients has enabled an impressive amount
of data to be amassed. Observations of Kraepelin,
Jaspers and Fish have culminated with the development
of instruments such as the Present State ExaminationT for
the classification of psychiatric symptoms.
However, there needs to be general agreement on just
what cluster of symptoms constitutes which particular
syndrome or disorder. This agreement on what constitutes
a particular disorder is most important for accurate
communication. That wide disagreements have occurred
about what constitutes a particular disorder, \^/as clearly
demonstrated by the us - uK8 diagnostic project. In this
study, it was discovered, the greater number of patients
diagnosed as having schizophrenia in the us, as compared
with the UK, \^¡as not due to a different incidence of
schizophrenia, but rather to a broader concept of
schizophrenia used by American psychiatrists. American
psychiatrists tended to find higher levels of psychopathology
in all areas; they also had a much broader concept of
thought disorder. It thus appeared that, âs well as
significant criterion variance for diagnosis, there was
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between American and English psychiatrists. On the other
hand, results of the International Pilot Study of
Schizophreniae tended to suggest that, in general, apart
from psychiatrists in Moscow and washington, similar
concepts of schizophrenia v¡ere hetd by psychiatrists in
developed and underdeveloped countries throughout the
worId.
Given the state of the knowledge of psychiatric
disorders in the late '70s and the problems associated
with psychiatric diagnosis, the American Psychiatric
Association produced its third Diagnostic and Statistical
Manualr0 - DSM IIT in 1980. The DSM III provides explicit
criteria and decision rules for the diagnosis of psychiatric
disorders. The criteria are, in general, descriptive
apart from the few disorders where aetiology or
pathophysiological processes are known. The aetiology of
psychiatric disorders is to a large extent ignored by the
DSM fII classificatory system. As such, the DsM III is
open to the criticism of too early closure. Bronowskil I
has said: "A science which orders its thought too early
is stifled". However, the DSM III classificatory system
has met with acclaim from Feinstein, an authority on
clinicat judgment. Feinsteinr2 says of the inclusion of




"The Production of oPerational
iaentifications has been a pioneetitg
,tttiqrr" advance in nosologY
the field of diagnostic nosologY' the
establishment of operational criteria
represents a breakthrough that- is as
obi¡ious, necessarf r fundamental and
imPortant as the corresPonding
breakthrough in obstetrics and surgery
when Semmeiweiss, Oliver V'IendaII
Holmes and, Iater on, Lord Lister
demanded that obstetricians and
surgeons wash their hands before
opeíating on the human body "':'. The
absence ót such criteria is what has
made the rest of the ICD (International
Classification of Diseases) such a
shambles, because of the inconsistent
waY in which the nomenclature is
applied".
The DSM III system, then, is an attempt to define
the "what is it?" Problem of
makes no attemPt to address
psychiatric diagnosis; it
the question "hovt has 'it'
'i
,,{ occurred? "
In general medicine, even though clusters of symptoms
could be reco:gnised as diseases such as gout' with a
predictable natural history, the aetiology of such
d,iseases, the "how" question was only answered when
autopsy studies and laboratory technology' along with
animal experimentation, \^Iere developed' This is not to
say the "ho\nl" question was not addressed in general
medicine prior to the development of morbid anatomy and
Iaboratorytechnology.Thedesiretounderstandobserved
phenomena in terms of a general exptanatory theory is, of
course, not new. It is merely that prior to these
developmentsaetiologicaltheoriesinmedicinedidnot'
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Similar attempts to explain observed phenomena
occurring in psychiatric disorders in terms of aetiology
have, of course, occurred. Freudrs diagnostic
classification was based primarily on aetiology and not
on syrnptomatology, viz., the traumatic neuroses' the
actual neuroses and the psychoneuroses. Freudrs attempt
to arrive at a diagnostic system was flawed, according to
Brennerr 3, in not deriving from adequate data. He takes
as example two of Freud's diagnoses: neurasthenia and
anxiety neuroses. These syndromes had different dynamics
and different aetíologies.
"Excessive masturbation or nocturnal
emissions comprised the first group
of pathogenic, sexual abnormalítfes.
They Produce sYmPtoms of fatigue'
lisltéssness, flatulence, constipation,
headache and dyspepsia. Freud proposed
that the term neurasthenia be henceforth
timited to this group alone. The second
type of sexual noxia was anY sexual
activity which Produced a state of
sexual excitement or stimulation with
an adequate outlet or discharger âsr
for examPle, coitus interruptus or love
making without sexual gratification.
Such activities resulted in states of
anxiety, nost typically in the form of
anxiety attacks, and Freud proposed that
such patients be diagnosed as anxiety
neurosis " .
In a discussion of psychoanalytic diagnosis, StoIlerlq has
commented that psychoanalytic thinking has often confused
andthe distinction between "concomitant with"
"aetiological for".
Biological aetiological theories have been successful.
in provid.ing an understanding of the neuropathology and
I5
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Successful treatment of Some psychiatric disorders.
Most notable are probably the discovery of the association
between central nervous system infection by Treponema
pallidum and a general paralysis of the insane, and the
association between niacin deficiencies and psychosis.
Feinsteinl2 has commented on the impact of similar such
aetiological discoveries in general medicine. Wherever
what Ctráúd.e Bernard has called a "proximal causerr for a
disease was identified, there was a change in the name of
the disease. The old clinical entity of dyspnoea, for
example, became the pathological entity pneumonia. Later,
when its aetiology \Á¡as further understood, it became
staphylococcal Pneumonia.
However, generally the process of being able to
classify most psychiatric disorders on the basis of a
biochemical or physiological aetiology has not been
possibler âs it has been in general medicine. The search
for any pathology or disturbed physiology in the major
functional psychoses and the neuroses did not' tiII very
recently, prove fruitful. However, some "markers" of
disturbed brain function specific for certain psychiatric
diagnosis for example, a positive dexamethasone
suppression test in endogenous depressionl s - have been
discovered. such biological markers would appear to have
no particular immediate relevance to aetiology. They do,
however, add to the validit.y of diagnostic categories
such as endogenous dePression.
I6
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fn stünmary, it appears that the process of diagnosis
is generally applicable to the study of psychiatric
disorders. The history of the classification of diseases
in general medicine is similar to the history of such
classifications in psychiatry. It does appear possible
to establish diagnostic criteria for psychiatric disorders '
These disorders do follow a generatly predictable natural
history. An aetiologicat underpinning of psychiatric
diagnosis is less well established than in general
medicine. with a few exceptions, aetíological explanations
for particular diagnostic categories are not available.
3. The Process of Diagnosing in Psychiatry.
Let us now consider in more detait the process of
arriving at a diagnosis in psychiatry. Nurcombel6 has
considered the process to be similar to diagnosis in
general medicine. Accord.ing to Nurcombe and Fitzhenry-
Coor:
"From a cognitive standpoint, medical
problem soiving appears to be a set of
ðperations invótving memory organisation'
dãcision-making and ProbabilitY
estimation
The cognitive strategies are as follows:
1to) elicit, recognise and evaluate
salient cues; (to) assemble cue-clusters
in such a way as to delineate a clinical
problem; (to) develop a structured array
õt ai.gnostic hypothesesi 1to) develop
an enquiry strategy derived from the
array-of ñypotheséã; (to) weigh positive
and ñegative evidence; (to) formulate a
comprehensive and an individualised plan
of management".
I7
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They have produced evidence from a study of clinical
reasoning during psychiatric interviews, that experienced
psychiatrists produce more hypotheses earlier in the
interview than less experienced residents. They have
also shown that, with experience, clinicians became more
explicit in their explanations for particular decisions.
They also found that the more experienced clinicians v¡ere
more able to continuously re-evaluate early hypotheses in
the light of new information. There would seem' then, to
be no major differences in the logic of this schema for
diagnosis and that which Feinstein has described as
occurring in general medicine. Additional rules of
particular importance in clinical reasoning in psychiatry
are, according to Nurcombe and Fitzhenry-Coor, the
toleration of uncertainty and the avoidance of premature
closure on one possibility, the distinction between
observation and inference, al^tareness of personal reactions
to particular patients and the distinction between
accurate empathic identification and the projection of
personal conflicts onto patients.
However, LazarerT has suggested other factors may be
of importance in decision making in psychiatry. Lazare
describes four conceptual models used by psychiatrists
medical, psychological, behavioural and social. He
suggests that different courses of management arise from
each model, and that the psychiatrist's choice of which




the diagnosis applied to the patient (this may have' of
course, already been affected by a particular set held
by the psychiatrist), but also the effectiveness of
available treatments, the immediacy of the situation' the
social class of the patient and, lastly, the "ideology"
of the psychiatrist . Lazare refers to Armor and Klermanr 
I
who point out that "different ideological factions are
mostlikelytooccurwhenacodifiedknowtedgebaseis
markedly incomplete or ambiguous about the means to be
usedtoattainaprofessionalgoal'..Lazarefeelsthat
this is the current state in psychiatry. Ideologies in
psychiatry give sbray generally in the face of mounting
evidence supporting a particular treatment. For example'
theuseofpsychotherapyasaspecifictreatmentofmanic
depressive illness has waned with the introduction of
specifically effective treatment, Lithium Carbonate'
With respect to the importance of social class in
determining the psychiatrist's decision making' Lazare
refers to the work of Hollingshead. and Redlichle, where
the importance of social class in the application of
psychotherapy \^tas demonstrated' He uses the example of
the soldier who becomes psychotic at the battlefront as
an instance where the immediacy of the situation is of
importance in decision making'
Feinstein views diagnosis as not an end in it'self '
but rather as just part of the logical process of
19 
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deciding on a course of management for the patient. The 
assumption is, of course, that in general medicine the 
correspondence between diagnosis and a particular treatment 
is high. Is this the situation in psychiatry?· (Feinstein 
has enlarged upon f a ctors other than diagnosis which 
determine treatment decisions in general medicine, as the 
correspondence between diagnosis and treatment is ofte n not 
high in general medicine.» From the preceding discussion it 
would not appear to be so. Kendell 20 has echoed this point: 
"The existence of a treatment like 
cobalamin for pernicious anaemia or 
chloroquine for malaria, which is 
specific for a single diagnostic 
category and almost invariably 
effective o n members of that 
category .•.•. at present no such 
situation exists in psychiatry". 
Williams 2 1 has divided decisions about management of 
patients with psychiatric disorders into three leve ls. The 
first is the dec ision to refer the patient to a psychiatrist; 
the second is the psychiatrist's decision whether to admit 
the patient to hospital and the third is the decision of 
which specific treatme nt to use. Williams finds little 
evidence for the psychiatric diagnosis being greatly important 
in any of the s e d e cisions. 
Se veral studies h ave examined the r e lationship b e twee n 
diagnosis and management in psychiatry. Banniste r et al. 22 
examine d psychiatric case notes looking for associations 
b e twe en particular diagnoses and treatments. They found, in 
general, that a particular treatment did not follow a 
particular diagnosis. They t e ntatively conclude d that 
variable s other than diagnosis we r e important in predicting 
the course of treatme nt. Sandife r 23 looke d more close l y a t 
20 
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why psychiatrists differ in their decisions regarding 
treatment. He examined the diagnostic and treatment 
decisions of six psychiatrists who had watched a series of 
filmed interviews with patients. The psychiatrists' "sets" 
with respect to various treatment options such as psychotherapy 
and somatic therapies had been determined by a questionnaire 
given previously. He found considerable difference in 
treatment plans. Differences over the use of phenothiazines 
seemed best related to differences over diagnoses, while 
differences over whether to use psychotherapy seemed to be 
associated with the psychiatrists' "set" towards psychotherapy. 
Mayou 2 4 similarly found wide variations in treatment p lans 
when 43 experienced psychiatrists were asked how they would 
manage a typical psychiatric problem - a married woman 
presenting with agoraphobia and mild depressive symptoms. 
Particularly, differences were found with respect to types of 
further information required, type of treatment, number and 
frequency of treatment sessions and the use of other 
therapists. The lack of congruence between diagnosis and 
treatment may, in part , reflect the multi-factorial aetiology 
of psychiatric disorder. The DSM-III multi-axial diagnostic 
system recognises the importance of considering various facets 
of the patient ' s current condition when determining management 
plans. 
To recapitulate, the process of diagnostic decision 
making has been considered. Similarities have been drawn 
between decision making in psychiatry and the process of 
diagnosis in general medicine. The importance of factors 
other than diagnosis in decision making in psychiatry h as 
b een raised, as has the lack of specific treatme nts for 
-~- .. " ..,,...,,...hi ;::it-ri c disorders. 
21 
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Given the preceding discussion of the nature of 
diagnostic decision making and treatment in psychiatry, 
it will now be considered whether more formal methods 
of decision making theory can be applied to psychiatry. 
Before, the application of decision making models to 
general medicine will be briefly considered. 
4. Bayes' Theorem. 
Bayes' theorem of probability theory is, according 
to Edwards et al., 25 a formally optimal rule about how 
opinions should be revised in the light of new information . 
Lusted2 believes that the intuitive process of diagnosis 
and clinical decision making, as performed by experienced 
clinicians, approximates the Bayesian s tatistical process. 
He also feels that by making decision making more explicit, 
and perhaps directly applying Bayesian statistical methods , 
the accuracy of clinical decision making could be improved. 
The Bayesian statistical approach f inds an immediate 
application in the interpretation of laboratory test 
results. Following Galen and Garnbino, 26 Bayes' formula 
allows a calculation of the a posteriori probability of a 
disease 8 ·, ·J.given a positive laboratory test result R. The 
a posteriori probability is the predictive value of a 
positive test result. To calculate the a posteriori 
probability, the following data is required: 
22
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(I) An estimate of the prevalence of the
disease 0r is required' p (0r) is the
q. prior'í probability of the disease in
the PoPulation;
(2) An estimate of the prevalence of non
disease or other disease states is
required. p (02) is then the a pt'iori
probability of non disease or other
disease states in the communitY'
0r and Qz are mutuallY exclusive
P (0r) + P (02) = 1'
ThepredictivevalueofapositivetestresultR,p(er/R)
is given bY BaYesr theorem:
p (0r) P (R/er)
P (0rlR) p (er) P (R/er) + P (oz) P (R,/0 z )
Note: p (R/e r ) is the probability of a positive test
result R, given that the patient has disease 0 r '
It represents the test sensitivity'
p (R/e2) is the probability of a positive test
result R given the patient has other diseases
or no disease 02. It is equal to I minus test
spec ificity.
23
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The importance of the a prioni probability of the
disease (its prevalence) in the population in which a
particular test is used, was forcibly stressed by Galen
and Gambino. The predictive value, derived from Bayesl
theorem, is the value which determines how accurately a
test wiII predict the presence or absence of disease.
The prevalence of the disease in the population under
study profoundty affects the predictive value, far more
so than common sense would suggest-
Galen and Gambino cite, as an example of the importance
of the prevalence of the disease under consideration, the
test for Phenyl ketonuria (PKU) . In this case the test
has very high specificity and very high sensitivity;
howeverr âs prevalence of the disease is so low, the
predictive value of the test is only 50å. This means
that half the abnormal test results occur in subjects
without PKU. This is what occurred when PKU screening
became mandatory for all newborns.
Galen and Gambino state that the variables of
sensitivity, specificity and prevalence and predictive
value apply not only to laboratory test results but also
to questions in the clinical interview. This is not
surprising when it is considered that the predictive
value is derived from Bayesr theorem whichr ês has been
said previously, can be viewed as a formatly optimum rule
for revising old opinions in the light of new information'
24
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Galen and Gambino further illustrate the effect of
prevalence with an interesting explanation of the results
of Rosenhan'ss pseudo-patient study. If the prevalence
of sanity is low in a psychiatric hospital, less than
0.18, even if a psychiatrist can diagmose sanity with 95t
sensitivity and 95t specificity, the predictive value of
a positive result is only 2t. A false positive rate of
98S is so poor that any attempt to discover a very few
sane amongst a massive number of insane would be unrewarding'
5. Bayes' Theorem and PsYchiatric Diagnosis.
The application of Bayes' theorem to decision making
in psychiatry will now be considered further. Kraus2T
derived a prediction of suicid'al risk by applying
conditional probabilities for suicidal behaviour with
respect to variables of a9ê, sex and diagrnosis to Bayes I
formula. He derived his data from psychiatric hospital
case notes. He was thus able to produce postetior
probabilities for the risk of suicide; for example, in a
woman, aged 40, with a diagmosis of reactive depression.
Kraus also employed Bayesian statistics to derive the
Iikelihood of a particular diagnosis, given the prevalence
of the disorder and conditional probabilities for various
symptoms. Kraus points out that by judicious adjustment
of prior probabilities it is possible, using Bayes'
theorem, to minimise undesirable decision errors.
25
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Mellergard and Lerolt2 I similarly derived conditional
probabilities for the presence of certain variables
including family history of mental illness, previous
hospitalisation, previous treatment, specific symptoms'
etc., in various psychiat.ric disorders. Using Bayesian
statistics, they were able to give an indication of the
value of a particular piece of data (for example, social
history) , f..or a particular diagnosis (for example'
schizophrenia) . They \^rere also able to indicate which
parts of the psychiatric interview were likety to be of
most importance for the diagnosis of a particular psychiatric
dísorder.
In a further paper, Mellergard and Leroy2s compared
the diagnoses generated from conditional probabilities for
symptoms using Bayes' theorem with actual clinical
diagnostic decisions. They looked at the differential
diagnosis between "endogenous depression" r "neurotic
depression" and "anxiety neurosis". They found that the
clinician's d,iagnosis of endogenous depression occurred
with greater frequency than was expected according to
Bayes' theorem. That is, the diagnosis of endogenous
d.epression was made more often than the information base
indicated it should be made. Mellergard and Leroy relate
this observation to the inclination of the clinician to
give the patient a trial with antidepressants. The
clinicians behaved as if the prior probability of endogenous
depression was higher than it actually \^Ias. According to
26
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Edwards30 ',people maximise the product of utility and
subj ective probability" .
pilowsky and Durbridge3 I have devised a Diagnostic
Utility Index which is a method for eliciting attitudes
of clinicians to the diagnosis of a variety of conditions '
It provides a measure of the concern the physician has
over misdiagnosing a particular condition and relates,
of course, to the nature of the condition and the available
treatments.
To conclude, the difficulties of diagnosis in
psychiatry have been considered, along with the relevance
of diagnosis to management. Other factors, such as the
psychiatristrs "Set" have been reviewed. The complexities
of the decision making process have been touched upon and
examples of using an algorithm, Bayes' theorem, as a
device to help understand clinical decision making, have
been discussed. In the light of this re-evaluation of
decision making, diagnosis and treatment, the next chapter
will re-evaluate the literature on the development of the
DST as a specific test for melancholia.
27
CHAPTER TWO:
THE DEVELOPMENT OF THE USE OF THE DST IN PSYCHIATRY:
I Cortisol Levels in PsYchiatric Disorders.
"An imPortant research area in
psychosomatic medicine concerns the
ielationship of various emotional
states to aãrenal cortical activation" '
Thus began Rubin and Mandell'sl review of
psychoneuroendocrinotogy in L966. By the mid-'60s the
success of physical treatment such as electroconvulsive
therapy, neuroleptics and tricyclic antidepressants in
treating psychoses, had given a firmer basis to the
contention, held since Hippocrates formulated melancholia
in terms of an imbalance of "humours", that some
psychiatric disorders had a physicat or organic basis '
In 1965 Schildkraut2 had formulated the "biogenic
amine hypothesis" of affective disorders. The hypothesis
states that:
"Some, if not aII, dePressions are
associated with an absolute or
relative deficiency of catecholamines 'particularlY norePinePhrine, ât
functionally important synapses in
the brain. ConverselY, elation maY
be associated with an excess of such
amines".
This ',biogenic amine hypothesis" is based, in part, oD
observations that drugs such as mono-amine oxidase
inhibitors and tricyclic antidepressants, which potentiate
brain amines, cause activation and have an antidepressant
effect. Conversely, drugs such as reserpine, which d'eplete
brain amines, have a sedative or depressant effect'
2B
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In their review, Rubin and Mandell described the
work of Nauta3, who had. characterised the lateral
hypothalamus as the nodal point in both the ascending
and descending paths of the "limbic system mid-brain
circuit," and the cells of the medial hypothalamus as a
final common pathway for the influence of subcortical
neuron nets on the endocrine system. The role of limbic
system structures in the modulation of emotional behaviour
had been known since the work of Papez\. Rubin and
l"fandell claimed that "the possibility of using
endocrine-d.epend.ent variables as reflections of limbic
system function in man may be an important ne\^¡
neurophysiological approach " .
By 1966 adrenal cortical activity in several
psychiatric disorders had been studied. The difficulty
with much of this work was in deciding whether it was the
"stress" of the psychiatric disorder or the psychiatric
disorder itself which brought about the observed changes
in adrenal activity.
Persky et al.s in a series of studies found that, in
general, plasma and urinary levels of L7 hydroxycorticoids
were greater in anxious, hospitalised psychiatric patients
than in normal controls. Sachar et aI.6 studied four
young males with schizophrenia with respect to urinary
excretion of 17 hydroxycorticoids. They found that periods
of heightened corticoid excretion were characterised by
a breakdown of "psychological defenses". They
"29
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hypothesised that corticoid excretion was influenced not
by the type of defense, ví2., neurotic or psychotic' but
rather by its effectiveness against anxiety'
with respect to affective disorders, several studies
of adrenal function in depression and mania had been made
by the mid-,60s. They had generally revealed increased
production of corticoids during depression. some studies'
such aS that of GibboDST, had shown a return to normal
Ievels after treatment with ECT or antidepressants.
Bunney et aI.8 studied a 43-year-old woman with a rapid
cycling bipotar affective disorder. consistent decreases
in 24 hour urinary 17 hydroxycorticoids on this patientrs
manic days and consistent increases on the depressed days
were reported. Absolute Ievels of 24 hour excretion on
aII days were always within limits of normal variation,
but the day to day fluctuations were consistent and there
were statistically significant differences between manic
anddepresseddays.Likesacharetal.,Bunneyetal.
viewed the increased steroid excretion on the depressed
days as a concomitant of decreased psychological defense
strength against anxiety, while the decreased steroid
excretion on manic days reflected an absence of anxiety
and a lack of "a\¡Iareness of illness"'
This notion of the ,.stress'' of the psychiatric
disorder and not the disorder itself, Ieading to
alterations in cortico-adrenal activity' was to hold s\^Jay
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discussed later, Rubin and Mandell did offer alternative
hypotheses. Bunney and Faucette had demonstrated high
mean levels of 17 hydroxycorticosteroid leveIs in three
patients who committed suicide, but had showed relatively
Iow clinical ratings of suicidal behaviourr âr observation
which tended not to fit the above hypothesis. Rubin and
Mandell suggested that perhaps the variations in
corticosteroid levels seen in some psychiatric disorders
might be affecting, if not causing, the emotional state
itself. They went on to discuss the psychological changes
reported in patients with Cushing's disease, and to
describe the depression, apathy and suicidal ideation
Seen in many patients. They commented: "Depression may
be a central nervous system response to high circulating
gluco-corticoids',. They then commented on a further
possibility, that "functional depressive states are
concomitants of a supra-hypophyseal brain dysfunction
which is also responsible for hyperstimulation of the
anterior pituitary". In other words, they were suggesting
that hypercortisolism might be a specific symptom of
certain depressive illnesses.
2. The DST and Affective Disorders.
Dexamethasone suppression tests (DST) were used widely
by the mid-,60s to help establj-sh a diagnosis of cushing's
syndrome. Liddlet0 had reported in 1960 that low doses
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coirtisol in normal subjects, did not suppress cortisol in
patients with cushing's syndrome, thus indicating a
disturbance in the feedback control of corticotrophin
release.
In 1968 Butler and Besserl r reported the results
of dexamethasone suppression tests before and after
treatment in three patients with severe "primary affective
disorder" who l^Iere otherwise physicalty healthy' Butler
found in his three depressed patients a resistance to
dexamethasone suppression similar to that seen in cushing's
syndrome; however, after treatment with a combination of
ECT and antidepressants, this abnormality was not present'
Butler commented that "since Severe depression may be a
presenting feature of Cushing's syndrome, diagnostic
confusion could arise in patients with primary affective
disorder".
In the same year Carroll et aI' 12 reported the
results of dexamethasone suppression tests (OST') in a
series of 27 patients with severe depressive illnesses,
before and after recovery, and in a control group of 22
patients with other psychiatric disorders. In this study
blood samples for estimation of 1I hydroxycorticosteroid
( It-oHCS) were taken at 8. 30 a.m. and 4 ' 30 p'm'
Dexamethasone phosphate 2 mg was given oralIy at midnight
and a further plasma sample taken at 8'30 a'm' the next
day. The mean II-OHCS leve1s at 8'30 a'm' after
dexamethasone were 13.I (ug/I00 mI) (so 7'0) in the
Þ
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depressed patients, 5.3 (ug,/I00 mI) (SO 5.I) in the
recovered depressed patients and 4.8 (ug/100 mI) (Sp 3.7)
in the non-depressed patients. The difference between
the depressed and non-depressed patients was sigmificant
at the 0.001 leveI. The leve1s of II-OHCS in each group
of patients at 8.30 4.m., prior to dexamethasone, were
not significantly different. Carroll et aI. commented
that the results showed that the dexamethasone suppression
test (OSr) discriminated between two groups of patients
(depressed and non-depressed) who have identical basal
morning plasma II-OHCS levels. They highlighted the
inadequacy of single estimation of plasma levels of II-OHCS
as an index of pituitary-adrenal function.
In I97I, in a study of 24 patients with various
psychiatric disorders, Shopsin and Gershonr3 were unable
to replicate Carroll's findings. They also found higher
morning cortisol levels in schizophrenic patients compared
with depressed patients. They were unable to explain the
disparity between their findings and CarroII's. They
underlined the critical need for:
"considering an individual's perception
of, and adjustment to, stress when
evaluating the significance of steroid
activity as related to psychiatric
diagnostic entitiesil.
They supported the notion that the non-specific "stress"
of the psychiatric disorder produced any observed changes
in corticosteroid levels.
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Sachar et aI.llrwho favoured the explanation that
increased adrenocortical secretion was not a characteristic
of depressive illness per sêr but rather was associated
with "affective arousal" and "psychotic decompensation'r
which may be associated with depressive illness, produced
evidence to support this view in 1970. They studied
cortisol production in 16 depressed patients before and
after recovery by infusing intravenously CI4 tagged
cortisol and measuring urinary rnetabolites. They also
rated each patient with a Depressive Symptom Rating Form,
a schedule which rated "depressive symptoms" and 'laffective
arousal" and "psychotic disorganisation". They found that
changes in cortisol production following recovery from
depressive illness correlated well with changes in scores
for "affective arousal" and "acute psychotic decompensation"
but correlated poorly with changes in "depressive
symptomatology". Sachar et aI. felt that previous reports
of high levels of corticosteroids in depressed patienÈs
normalising on recovery vTere attributable to a confusion
in psychiatric nosologyi i.e., a confusion in deciding
what were depressive symptoms and what was affective
arousal.
In 1973 Sachar et aI.Is went on to investigate the
complex nature of cortisol secretion in normals, using a
technique of sampling blood through a venous cannula every
20 minutes over a 24-hour period. These studies revealed
that in normals cortisol is secreted in about eight major
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episodes each d"y, with sharp rises and falls in plasma
cortisol concentration. They then studied patterns of
cortisol secretíon using this technique in depressed
patients. Their find.ings led them to revise the
formulation that cortisol hypersecretion in certain
d.epressive illnesses was simply a stress response. They
found that depressed patients, while iII, secrete more
cortisol, had more secretory episodes and more minutes of
active secretion. Cortisol was actively secreted during
Iate evening and early morning when normally secretion is
minimal. After treatment, the depressed patients'
secretory patterns normalised. Sachar et aI. commented
that animal studies had shown that episodic secretion of
cortisol closely parallels episodic secretion of
adrenocorticotropic hormone (ACTH), and as the half life
of cortisol in his depressed patients was normal, then the
disturbance in the 24-hour secretory pattern \^¡as almost
certainly due to a change in the central nervous system
prograrnme regulating ACTH secretion. Thus sachar et aI.
now sa\^r the hypersecretion of cortisol in certain depressive
illnesses not simply as a stress response, but rather as
reflection of apparent limbic system dysfunction, along
with other disturbances of mood, appetite, sleep and
autonomic nervous system activity.
In L7TG CarroIIr6 published a study which gave further
support to the hypothesis that changes in corticosteroid
secretion seen in Some depressive illnesses \^¡ere not due
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to the non-specific stress of "psychological ego defense
breakdown". He studied a group of patients with primary
depression and a group with schizophrenia, comparing
cortisol levels and response to d.examethasone in each
group. Both groups showed a high level of "ego defense
breakdown" aS measured by Sacharrs criteria. The depressed
patients had elevated free cortisot excretion, high
cortisol CSF levels and did not show normal suppression
in response to dexamethasone. Despite the presence of
severe ego defense breakdown and some secondary depressive
symptomatology, the schizophrenic patients had normal
hypothalaniiepituitary-adrenal function. Carroll concluded
from this study that there was a hypothalamic limbic
system dysfunction occurring in some d.epressed patients
with primary depressive illness, and that this dysfunction
was similar, but less severe, than that occurring in
Cushing's disease. The results lent support to the early
hypothesis of Rubin and Mandell.
AIso in Lg76, Carroll et aI. I 7 reported the findings
of a study where the effect of dexamethasone in patients
with primary depression $tas monitored using venous cannula
techniques. Blood samples were taken every 30 minutes for
24 hours before and after dexamethasone 2 mg was given.
Carroll et aI. !,¡ere investigating the importance of the
time course of the suppression response in detecting what
they assumed to be a subtle abnormality of hypothalamic
pituitary adrenal function occurring in depression. In
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other $rords, if more frequent blood samples were taken
on the day after dexamethasone, then possibly these
abnormalities might be detected. In fact, the catheter
studies revealed an "early escape" from suppression,
rather than an absolute resistance to Suppression by
dexamethasone in d.epressed patients. often a pattern of
"initial Suppression" was followed by this "early escape"
from dexamethasone suppression. carroll et al. felt that
this finding was able to explain the negative findings of
shopsin and Gershon's study, where a single morning blood
sample was the sole index of suppression.
Carroll et aI.I8 also reported on the results of
dexamethasone suppression tests in a series of 42 patients
with "endogenomorphic depression" and 42 patients with
other psychiatric disorders. The DST procedure in this
series included a 2 mg dose of dexamethasone given at
11.30 p.m. and plasma samples taken at 8 a.m-, 4 p.m' and
1I.30 p.m. the following day. urine samples were also
taken. Cortisol was measured using a competitive protein
binding method. The endocrine literature $¡as reviewed
to obtain criteria for judging whether measured cortisol
values were abnormal. Patients taking phenytoin or
phenobarbital !.rere excluded because of these drugs' ef fects
on dexamethasone metabolism. They found the plasma and
urinary cortisol results before dexamethasone administration
did not distinguish the endogenous depressive group very
effectively. The cortisol values after dexamethasone \¡Iere
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considerably more powerful as discriminators between the
endogenous and the "other" group. About half the endogenous
group had abnormal suppression and at least one post-
dexamethasone sample, and no pat.ient with a depressive
neurosis had an abnormal result. On the basis of t'hese
results Carroll et aI. claimed "We wish to caII attention
to this test as a promising laboratory aid in the diagnosis
of rendogenousr depressive states".
In ]gTg Brown et al.ls were able to replicate Carroll's
findings. In a series of 54 patients given the DST' they
found that 4OZ of those with a diagnosis of major depression
were non-suppressors after dexamethasone. They used a
similar protocol for the DST as in Carroll's L976 study.
None of the patients with other psychiatric diagnoses had'
abnormal suppression. similarly, Brown et aI. found that
the II.30 p.m. blood sample identified the highest proportion
of patients with endogenous depression. Brown et al. \â¡ere
not able to identify any differences in symptom patterns
between those patients with major depression who did
suppress after dexamethasone and those who did not. They
found a higher proportion of those who did not suppress
(57S) responded well to treatment than in those who did
suppress (20t).
NuIIer and Ostroumova'0 in 1980 published a report on
dexamethasone suppression in 52 patients with endogenous
depression and a control group. They attempted to increase
the sensitivity of the test for depression by reducing the
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dose of dexamethasone to 0.5 m9. Using this technique
they found 69t of the group with endogenous depression
were resistant to dexamethasone suppression, while 9* of
the control group showed resistance to suppression. They
reported the normalisation of dexamethasone suppression
when their depressed patients were in remission'
3. A Standardised Form of the DST.
In 19BI Carroll et aI.2r published an article entitled
,,A Specific Laboratory Test for the Diagnosis of Melancholia,
standardisation validation and clinical utility". They
began by stating that "An objective laboratory procedure
to assist in making the diagnosis of melancholia would be
useful" considering the longstanding difficulty in




Diagnoses r¡rere made by consensus by an interviewer' who had
administered the schedule for Affective Disorders, and a
psychiatrist. These clinical diagnoses \^tere supported by
RDC diagnoses in 958 of cases. The prevalence of melancholia
in the group was 588. Severity of depressive symptoms was
also assessed. Exclusion criteria included patients who
were undiagnosed (22',), who had schizo-affective disorder
and those with borderline personality disorder. Medical
exclusion criteria included concurrent administration of
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drugs known to affect dexamethasone metabolism, pregnancy,
severe weight loss, uncontrolled diabetes mellitus, major
physical illness, temporal lobe epilepsy, acute alcohol
withdrawal, high dose barbiturates and endocrine disease'
Both inpatients and outpatients blere inctuded. The dose
of dexamethasone administered was either I mg or 2 m9.
Blood was obtained at Il.30 p.m. prior to dexamethasone
and at 8 a.m., 4 p.m. and I1.30 p'm' the following day'
Intheoutpatientsampleonlythe4p.m.post-dexamethasone
sample was obtained. Plasma cortisol was assayed using
competitive protein binding techniques'
Abimodalpatternof4p.m.cortisolvalueswasfound




for the diagnosis of melancholia. They found amongst a
sample of 70 normal subjects about 4t had non-suppressing
results; this rate was similar to that in patients who did
not have melancholia. They found that lowering the d'ose
of dexamethasone from 2 mg to I mg increased the sensitivity
of the test from 39t to 67t without affecting the
specificity. They found that the 1I.30 p.m. pre-dexamethasone
cortisol level was not highty specific for melancholia'
There was no difference in the proportion of males or
females with melancholia who \^¡ere detected by Èhe test'
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carroll et al. savr as evidence for the face validity
of the DST its high specificity and predictive value-
Further evidence for face validity came from the increasing
number of non-suppressing results, with increasing
"certainty of diagnosis" of melancholia. Pred¡irctive
validity was reflected in the failure of conversion to
normal of the DST being associated with early relapse-
Construct vatidity was demonstrated by the reversion to
normal of the test with treatment. CarroII et al. stated
that construct validity also came from the fact that the
neuro-endocrine abnormality revealed by the DST indicates
dysfunction in the hypothalamus and the limbic system' the
proposed site of dysfunction in the affective disorders.
Thus 16 years after Rubin and Mandell's comments about
the nature of cortisol hypersecretion in some depressive
illnesses, the DST was reported as a simple laboratory test
for endogenous depression with considerable utility and
validity
4. Use of the DST in Psvchiatry in Recent Times.
In the last three years a large number of publications
has appeared examining the DST and its application to
clinical psychiatry. A non-exhaustive medline search of
the literature on the DST and its application to psychiatry
revealed a dramatic increase in the number of publications
in the period Ig79-83, in comparison to the previous decade.
The following section will review some of these publications.
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In 198I Asnis and Sacher et aI.22 , whose previous
work had shed much light onto the complexities of cortisol
hypersecretion in depression, reported on the ability of
the DST to unCover cortisol hypersecretion in depressed
patients. The assumption tested was that resistance to
dexamethasone suppression was a reflection of increased
hypothalamic-pituitary-adrenal activity. Asnis and Sacher
found that the DST was a highly specific test for cortisol
hypersecretion, but that it was not very sensitive in that
only 508 of cortisol hypersecreters (confirmed by cannula
studies) showed resistance to dexamethasone. They used
2 mg of dexamethasone in their DST and they suggested that
a lower dose may have increased the sensitivity of the
test for cortisol hypersecretion, the presumed "parent
abnormality" in depression. Asnis and Sachar2 3 have more
recently produced evidence showing that amongst endogenously
depressed patients cortisol hypersecretion was highly
correlated with shortened REM latency, another presumed
marker of biological à"nt"==ion. They hypothesise that a
noradrenergic deficit or a cholinergic excess may be
responsible for the association of cortisol hypersecretion
and shortened REM latency in biological depression.
concurrent with the development of the DST, other
neuro-endocrine disturbances occurring during depression
have been investigated by Prange and Loosenzq and others.
In particular, it has been noted that 25-35t of endogenously
depressed patients have a blunted thyrotropin (TSH)
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response to intravenous administration of thyrotropin-
releasÍng hormone (TRH). Targum et aI';2s reported in I9g2
that by,perfotming the TRH test and the DST' the combined
sensitivity of both tests Ín identifying major depressive
disorder was 67t with 92t specificity. They found that
onty llt of their sample of 54 depressed patients had
both abnormal DST and TRH responses, suggesting that the
hypothalamic-pituitary-adrenal dysfunction and' the
hypothalamic-pituitary-thyroid dysfunction, which occur
in depression, were independent phenomena.
Initiat reports of the use of the DST Ì^rere based on
inpatient populations. Several studies have reported on
the use of the DST in outpatients. Jaffe et aI.26 reported
the DST to be positive in three out of seven outpatients
diagnosed as having major depression with melancholia.
None of t5 patients with major depression without melancholia
had a positive DST. Other authors, Peselow et aI-27 and
Rabkin et aI.28 have not found the DST to be a sensitive
diagnostic indicator tot 
"rrdogrenous 
depression in larger
outpatient populations. Peselow et aI. in 1983 did report
a statistically greater frequency of abnormal DSTs in
depressed. outpatients than in normal controls.
over the last three years a number of reports have
appeared where the DST has been used to give "objective
support" to classification systems of depressive illness.
CarroII had always stressed the specificity of the DST for
the endogenous sub-group of depressive disorders. In a
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replication study of Carroll's I976 findings, Schlesser
et aI.2s found resistance to dexamethasone in 439 of
their 96 depressed patients and in none of their 80
controls who had other psychiatric disorders. They
classified the depressed patients into those with either
"familia1 pure depressive disease (FPDD) " or "sporadic
depressive disease (SDD) " or "depressive spectrum disease
(DSD) " following the classification system of Vüinokur for
primary unipolar depression. This schema has been supported
by clinical and genetic evidence. .schlesser et aI. found
the greatest percentage of non-suppressors in the FPDD
group (828), and the sDD group had 37t non-suppression and
only 4Z of the DSD group had non-suppression. Schlesserrs
findings of a greater proportion of non-suppressors in
FPDD than in DSD were supported by a series reported by
Targum et aI.30 in L982 and by Coryell et aI.3t in L982.
However, Rud.orfer et aI.32 reported they had been unable
to replicate the findings of Schlesser et al. that there
$¡as a higher rate of pSf non-suppression amongst patients
with family pure depressive disorder, FPDD, than in
depression Spectrum disease, .DSD,. or in sporadic depressive
disorder, SDD. Rudorfer et aI. found the highest rate of
non-suppression in the SDD group. Kasper and Beckman33
simitarty found that DST non-suppression was not more
prevalent in FPDD patients.
Schatzberg et aI.3q reported sigrnificantly higher rates
of non-suppression in unipolar as opposed to bipolar
depression. They also found significantly higher levels
44
THE DEVELOPMENT OF THE USE OF THE DST IN PSYCHIATRY
of post-dexamethasone in patients with depression and
psychosis compared with those depressed patients without
psychosis. Evans et al.3s similarly found significantly
higher post-dexamethasone cortisol levels in patients
with major depression with psychosis.
CoryeII and Schlesser36 examined any relationship
between suicide and DST non-suppression. Earlier Bunney
and Fawcett (see p- 30) had reported an association between
suicidal behaviour and high levels of urinary L7 OHCS.
They reviewed 243 patients with unipolar depression who
had been given DsTs. over a period of three years, five
of these patients committed suicide. of these five, four
had been diagnosed as having primary depression and each
had had abnormal DST responses. None of the remaining
IO9 patients with primary depression committed suicide.
The fifth patient who committed suicide had been diagnosed
as having a secondary depression; her DST response was
normal. In 1983 Targum et aI.37 reported a significant
association between attempted suicide and abnormal DST
in a group of 49 inpatients with Research Diagnostic Criteria
(RDC) diagnoses of primary unipolar depression.
That endogenous depression may be difficult to
diagnose on phenomenological grounds alone is well-known,
and the development of concepts such as "masked depression"
reflects this difficulty. Several reports have addressed
the issue as to whether the DST coutd act as "symptom
independent" objective marker of depression where the
slrmptom pattern was confusing or atypical'
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Greden and Carroll38 reported on the efficacy of the
DST in identifying an underlying affective disorder in
patients with catatonia. They reported a single case
where a râtoman with features of catatonia had abnormal
dexamethasone Suppression. She was successfully treated
with ECT and lithium carbonate. The use of EcT' a
treatment generally for:nd most effective in endogenous
depression, in successfully treating catatonia, is well
established. The presence of similar and identifiable
neuro-endocrine dysfunctions in both catatonia and
depression appeared to give a rationale to the effectiveness
of ECT in catatonia.
Evans and Nemenoffss and Krishnan et aI'q0 have
reported rates of abnormal dexamethasone suppression in
mixed bipolar disorder similar to those occurring in
endogenous depression. Targuma I reported higher rates
of neuro-endocrine dysfunction (abnormal DST or abnormal
TRH response) in patients who went on to have complete
recovery from .n ."rrtå schizophreniform disorder'
Gwirtsman et a1.a2 have reported a 672 rate of DST
non-suppression in a group of patients with bulimia' none
of whom was markedly underweight. In Lg82 Blumer et al'h3
used a 508 non-suppression rate in a series of patients
with chronic pain to support their contention that some
forms of chronic pain are a variant of depressive disorders'
There are, of course, two lines of argument with
respect to these findings. Firstly, it could be argued
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that some forms of mixed bipolar disorder, bulimia,
schizophreniform disorder and chronic pain disorder are
symptomatic manifestations of an "underlying" disorder.
The alternative explanation is that Èhe DST is simply not
highly specific for dePression.
Reusq b has reported on the use of the DST as the
independent variable in a group of I18 psychiatric
inpatients. Reus states, in a manner reminiscent of
C1aude Bernard (see P' 15) :
"This approach derives from the belief
that thã biological variable under
examination may possess more clinical
relevance than that provided by the
global diagnostic labe1, much in the
same way as a sputum culture provides
more information about cause' course'
and appropriate treatment of pneumonia
than tñat- afforded ry the clinical
diagnosis, with its attendant signs
and sYmPtoms " -
Reus found that, regardless of diagnosis' failure to
suppress cortisol following the DsT identified patients
with an increased incidence of sleep disorder, feelings
of anxiety and thoughts of suicide.
ward et aI. b s reported in LgB2 a single case study
where the results of the DST v¡ere useful in the treatment
of a 64-year-old woman with a history of an affective
disorder who presented wit'h slrmptoms suggestive of
paraphrenia. They reported "uncertainty about her
diagnosis led to uncertainty about which treatment to
pursue". She made tittle response to three ECT treatments;
atthisstageaDSTnon-Suppressingresultwasobtained:
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,,The DST provided a greater degree of diagmostic certainty"
thatECTshouldcontinue.ThepatientmadeagoodresPonse
with seven ECTs. The authors commented: "If a patient
with paranoia and a history of depression demonstrates
non-suppression on the DST, the clinician might reasonably
treat the patient with antidepressants or ECT and feel
confident this course of action should be aggressively
pursued".
Several psychiatric conditions appear to respond to
treatments generally considered specific for other
psychiatric conditions. For examPle, patients with panic
attacks and agoraphobia have been reported to respond to
anti-depressants such as imipramine and phenelzine' In
agoraphobia and panic attacks who had received DsTs' They
found three patients with abnormal DST results and they
attributed these results to alcohol withdrawal (two
patients) and concurrent depression (one patient). Thus
they concluded that, while patients with panic attacks
and agoraphobia may respond to imipramine or phenelzine'
,'antidepressant'! medication, there was no neuro-endocrine
dysfunction suggestive of an "underlying depression" in
these patients. In 1983 Sheehan et aI'r7 and Lieberman
et al. a I confirmed these findings '
Papers began to appear about this time reporting on
the use of the DsT as an index of recovery from depressive
illness. Albala et al.ae reported on changes in DsT
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response occurring during a course of ECT in patients who
$rere depressed and were initiatly resistant to suppression.
Six patients htere studied; in five the DST response had
normalised after 4-5 ECTs. The normalisation of the DST
often occurred before significant clinical improvement was
evident. The DST remained abnormal in the one patient who
did not respond to the ECT. Albala et aI. concluded that
the DST was a "successful biological monitor of clinical
response'r. HOweVer, these results \âIere ngt Confirmed in
a preliminary report by Decina et al.s0 in 1983. In a
further report, Greden et aI. s t examined outcome in patients
who, while they had shown clinical improvement after
treatment, remained DST resistant in comparison with
patients who showed both clinical improvement or reversion
to DST suppression after treatment. The "non-normalisers"
had a significantty poorer outcome, \^¡ith more relapses and
rehospitalisations. The authors suggested that a DST
performed prior to discharge may enable the clinician to
decide on the most appropriate course of management: "If
the repeat DST is abnormal, clinicians should be skeptical
recovery has occurredr'. Goldbergs 2 reported similar
findings and stated: "I strongly urge physicians to have
both cl-inical and neuro-endocrine evidence of remission
before discontinuing antidepressant therapy". Greden
et al.s3 reported in 1983 on the use of serial DSTs to
monitor improvement in a group of 3I depressed patients
treated pharmacologically. They found that most
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non-suppressors became Suppressors in conjunction with
clinical improvement, that DST normalisation often preceded
clinical improvement and that failure to normalise was
often associated with poor clinícal outcome.
The effects of various antidepressants on the DST
have also been investigated. Amsterdam et aI.sa investigated
any confounding effects tricyctics may have on the DsT.
A group of L2 patients with primary affective disorders,
who were initially suppressors prior to tricyclic
antidepressant treatment, remained suppressors three weeks
after treatment with the drug. It was thus concluded
that tricyctics induced no false positive DST results.
rn a preliminary report, Brown et a1.s5 found that
non-suppressing patients with depression responded
significantly better to imipramine and desipramine than
to amítriptyline or clomipramine. The reverse !{as true
for the group of depressed patients who were suppressors.
Brown et aI. hypothesised that DST non-suppressors have a
noradrenergic deficiency and thus respond preferentially
to imipramine and desipramine, drugs which are said to
have a pred.ominant effect on noradrenergic systems. DST
suppressors, meanwhile, have a serotonergic deficiency and
respond better to amitriptyline or clomipramine, drugs with
predominantly serotonergic effects. Frasers 6 reported
similar findings in 1983 in a retrospective study where
non-suppression on the DsT predicted good response to
noradrenergic antidepressants. Greden et aI.s7 were
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unable to repticate these findings. In a study of 26
non-suppressing depressed patients treated either with
imipramine or amitriptyline, they found no significant
differences in outcome. They concluded that the DST was
not able to assist in the choice of a particular tricyclic
antidepressant in the treatment of depression.
In a group of 34 patients with primary major
depression (RDC) Brown and Brawl"yt t administered the DST
and a methylphenidate challenge. They found the two tests
divided patients into two groups: one group failed to
suppress cortisol and faited to respond to methylphenidate
with a transient mood elevation; the other group suppressed
cortisol and did respond to methylphenidate transiently.
In an open trial the former group responded to amitriptyline
and the latter group to imipramine. Brown and Brawley
commented that the association between methylphenidate
non-response and cortisol non-suppression is surprising
if methylphenidate non-response is taken to indicate
noradrenaline "dysfunction". They added that explanations
of complex regulatory functions like CRF secretion in
terms of a single neurotransmitter abnormality are likely
to be misleading. In 1983 Jimerson et al.ss reported a
robust correlation between post-dexamethasone levels of
cortisol and plasma MHPG after dexamethasone, a result
not supporting the hypothesis that "noradrenergic"
antidepressants should be more effective in dexamethasone
non-suppressors .
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5. Problems with the Use of the DST in Psychiatry.
Atong with the increasing number of publications
indicating the utility of the DST as a laboratory test
in depression, there has also been a growing number of
reports, particularly within the last year, which call for
caution in the interpretation of results of the DST in
clinical psychiatry.
In a study of the DST in 53 healthy volunteers,
Amsterdam et aI.60 reported 15.18 showed non-suppression.
They commented on the fact that the incidence of early
escape from suppression after dexamethasone has not been
extensively investigated and. he added that "for data
obtained from the DST to have validity and interpretability,
appropriate internal controls must be employed". Hallstrom
et al.6l reported 193 of women given the DST in a population
study had non-suppressing results. There r¡¡ere no
differences between suppressors and non-suppressors with
regard to depressive symptoms.
The high specificity for melancholia or endogenous
depression was a factor in making the DST an attractive
laboratory diagnostic aid. In L982 Spar and Gerner62
called this high specificity into question in a report
where they performed the DST on L7 patients with a DSM III
diagnosis of dementia. None of the patients met DSM III
criteria for major depressive illness. Nine of the 17
had abnormal DST results and thus Spar and Gerner
suggested the DST be used with caution in distinguishing
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similarly found abnormal DST results to be related to
dementia and not, to age or depression in a study of
patients with Alzheimer's disease, multi-infarct dementia
and healthy controls.
Targum and Capodanno6q in 1983 reported the
predictive value of the DST for major depressive disorder
in adolescents to be only 282. Geller et al.6s reported
that onll¡ two of L4 children aged 5-L2 years $Iith DSM III
major depression hrere n6n-suppressors. These studies
indicate that the usefulness of the DST as a diagnosÈic
aid in patients where diagnosis is difficult, vi-z. children,
adolescents and the elderly, may be limited-
Coppen et aI.66 reported on the prevalence of
abnormal response to dexamethasone in a group of psychiatric
inpatients and normal controls. Eleven per cent of
controls had abnormal responses. Abnormal responses were
found in 70? of depressed patients, 202 of schizophrenic
patients, 258 of abstinent alcoholics, 409 of patients
with neurotic disorders and 5Ot of patients with dementia.
Diagnoses were made using the ICD-9 system. Holsboer
et al.6 7 reported a sensitivity of 23.72 and specificity
of B6t for abnormal DST results for endogenous depression
(ICD-9). They found L4.7* of patients diagnosed as
reactive or neurotic depression showed non-suppression.
The DST in this series consisted of 2 mg dexamethasone
with a blood sample for cortisol taken at 4 p.m. They
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r¡rith non-suppression, regardless of the diagnostic
classification, either endogenous or reactive. They thus
concluded abnormat DsT status appeared of "limited
predictive value for correct diagnosis".
Ivleltzer et aI. 6 I 'in L982 simitarly reported a
specificity of only 76.gt for primary depression, a figure
below that previouslY rePorted.
Winokur et al.6 e examined the response of a group
of 12 patients with primary depressive disorder and a
control group to a series of four neuro-endocrine
challenges thyrotropin-releasing hormone (TRH)'
gonadotrophin-releasing hormone stimulation, insulin
tolerance test (ITT) and overnight dexamethasolìe
suppression test (DST). They found that 96r^ of the
depressed patients had at least one abnormal response'
while 29.28 of the control group had at least one abnormal
response. They found that non-suppression after
dexamethasone occurred as frequently in the control group
(8.3t) as in the depressed group (7.72). There were no
consistent patterns of abnormalities. The authors
suggested that the hormonal responses in depressed
patients "are most accurately defined in terms of their
variability with respect to responses seen in healthy
subjects".
In I9g3 Edelstein et aI.70 reported on post-dexarnethasone
cortisol secretion in obese, depression-free patients
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r^reight loss; however, 272 faited to suppress after an
average loss of 13.5 kg. Failure to suppress was not
associated with changes in depression ratings. They
commented that in depressed patients with weight loss of
nine or more kilograms, DST confirmation of diagnosis
should not be relied on.
Newsom and l"lurray7t reported on the DST in detoxified
alcohol abusing inpatients. Thirteen of 75 patients
were non-Suppressors after intoxication; all had reverted
to normal suppression after four more weeks of abstinence.
No patients met DsM III criteria for major depression,
atthough all had initial subjective complaints of
depression.
Other reports have questioned the methods of
performing the DST. Meltzer and Fang72 reviewed various
methods of cortisol determination in current use and
found significant discrepancies. The most widely used
methodrthe radio-immuno assay methodr râY not produce
leveIs comparable to those produced by the competitive
protein binding method. Meltzer and Fang comment: "The
use of the DST by physicians should be preceded by an
assessment of the validity of the cortisol level
determinations in the critical range for the DST by the
laboratory they userr. Brown et a1.73 reported on
variations in results produced by using either I mg or
2 mg of dexamethasone. Goggans et aI.7a reported on
increasing the sensitivity of the DST by increasing the
number of cortisol sampling time points.
55
THE DEVELOPMENT OF THE USE OF THE DST IN PSYCHIATRY
A case report of Amsterdam et al.7s in 1982
questioned the use of the DST as a prognostic tool to
predict future depressive episodes. In the case reported
a patient, a non-suppressor, reverted to a suppressor
after treatment with antidepressants. Ten months aft'er
treatment she relapsed; a DST performed at this stage
showed her to be a suppressor. The case raised the question
as to whether DST non-suppression occurs with each relapse
for a particular patient. If a non-suppressor during one
episode of depression could be a suppressor during the
next episod.e, then the prognostic value of the reversion
of the DST would be limited. Coryell and, SchlesserTs
reported in I9B3 on DST results in patients during several
different hospitalisations for depression' They found
40.98 of patients whO were DsT non-suppressors on one
admission were suppressors on the other admission. They
commented that abnormal escape from dexamethasone may only
partialty overlap the depressive syndrome in time.
CarrollT 7 discussed the interpretation of DST results
in a review article in L982. In particular, he drew
attention to the fact that the "diagnostic confidence"
of an abnormal test result was 94t in a population where
the prevalence of endogenous depression was 50t. with
a Iower prevalence, the diagnostic confidence or predictive
value of the test is decreased. He therefore suggested
that the test not be recommended as a screening procedure
for all psychiatric patients and urged that clinicians
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avoid over-interpreting the test results. Baldessarini
et aI.78 in lgg3 discussed the predictive power of
diagnostic tests in psychiatry and the effect of
prevalence of illness. They commented that "basic
statisticat principles requíred for critical evaluation
of their value remain poorly integrated into clinical
thinking".
1o conclude, evidence for the hypothesis that a
sub-group of depressed patients has a specific neuro-
endocrine abnormality, has been reviewed' The use and
popularity of the DST to measure this abnormality has
been described. The increasingly large literature on the
use of the DST as a diagnostic tool, âD index of recovery
and a prognostic tool in the management of depression,
has been reviewed. Finally, the recent cautionary
Iiterature commenting on the need for care in interpreting
DST results has been discussed.
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The fotlowing study is not concerned with the i
diagnostic accuracy of the DsT for melancholia, nor is
it concerned with the nature of possible timbic system
abnormalities which might be reflected by abnormal
cortisol production in depression. It is rather concerned
with the effects of the introduction of this laboratory
procedure into clinical psychiatry. More specifically'
!.¡as the introduction of the DST associated with any
changes in diagnostic practice or treatment?
The DST was introducted to the Psychiatric unit of
the Royal Adelaide Hospital in March 1981, a few months
after CarroII et aI. I had reported on the utility of a
standardised form of the DST. Within the Psychiatric
unit of the Royal Adelaide Hospital use of the DsT was
generally encouraged, particularly in cases where
biological depression was suspected but difficult to
diagnose on purely phenomenological grounds' There was
no expectation that significant changes in diagnosis or
treatment would have occurred with the introduction of
the DST. To test this hypothesis a review of inpatient
notes was performed. This review permitted comparisons
of clinicians' behaviour with respect to diagnosis and
treatment before and after March 19BI.
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case-notes of patients at the psychiatric unit of the
Royal Adelaide Hospital \^rere reviewed.
The psychiatric unit at the Royal Adetaide Hospital
(a 900-bed general hospital) consists of a 24-bed ward-
Patients are referred from other wards in the hospital,
the emergency service of the hospital or from psychiatric
outpatients. A range of both somatic and psychosocial
therapy is provided. The average length of stay2 in the
ward is 19 days.
The two periods of the study were from March to
December 1980 prior to the introduction of the DST, and
from March to December 1981. A list of all patients
admitted during the periods was compiled from the ward
bed-state register. Details on over 908 of these patients
were retrievable from their case-notes. Information
abstracted from the case-notes included: age' sex, previous
psychiatric management, whether suicidal behaviour had
occurred, a depression rating score, the Levin6-Pilowsky
Depression Score (LPD) ,3 the DST result, treatment during
admission and on discharge, and the final clinical diagnosis'
The Levine-Pilowsky Depression Questionnaire was
routinely completed by patients on admission to the
psychiatric unit at the Royal Adelaide Hospital. The
questionnaire consists of 57 items requiring a yes or no
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ansvrer. It is self-administered. The questions relate
bothtopsychologicalandphysiologicalcomponentsof
depression and are based on statements related to
endogenous and neurotic depression in standard psychiatric
tests. The questionnaire yields a measure of the severity
of depression on a 2o-point scale. It also allows for a
classification of patients into three groups: non-endogenous
depression, endogenous depression and no depressive syndrome
present. The statistical method of numerical taxonomy is
used to give the most parsimonious method of grouping
patients on the basis of their responses to the question-
naire, thus forming the three LPD "classes"'
The final clinical diagnosis was that made by the
treating trainee psychiatrist when writing the discharge
sunmary at the completion of treatment. These diagnoses
\^¡ere a combination of ICD-9 diagnoses' some DSM III
diagnoses and some local variations of both systems. To
overcome the problem of multiple diagnostic terms being
used in the reviewed case-notes, the recorded diagnosis
v¡as allocated to one of four classes (Table 3'1) ' This
allocation $¡as made soleIy on the basis of the discharge
diagnosis" In the results which follow the term "biological
depression" was applied to classes a + b combined.
60
A RETROSPECTIVE STUDY OF THE IMPACT OF THE INTRODUCTION
OF THE DST ON THE DIAGNOSIS AND MANAGEMENT OF PSYCHIATRIC
INPATIENTS:
TABLE
Classification of final psychiatric diagnosis





depressed phase manic depressive illness





d all other diagnostic terms.
From March I98I a version of the DST protocol similar
to that of Carroll was used at the Royal Adelaide Hospital:
I mg dexamethasone phosphate $ras given orally at II.00 p'm'
on day I. On day 2 blood was drawn for cortisol estimations
at 8.OO a.m., 4.OO P.m. and tI.OO p.m. Cortisol levels
\â/ere assayed using a radio-immuno aSSay technique (Amerlex'
Amersham Kit.). A plasma cortisol result greater than
160 nmol/l in any of the three samples was taken as a
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This cut-off point differs from that suggested by Carroll
who suggests 138 nmol/I (S ug/dL). It is the cut-off
point used at the Institute of Medical and Vetinary Science
in Adelaide. It was deduoed from probit analysis of
tocal patient data and validated by data obtained locally
from normals. AII cortisol assays were performed at the
Institute of Medical and Vetinary Science. CarroII's
exclusion criteria for medical conditions and drug
treatment, where the DST was likely to be misleading, $/ere
applied. The DST was usually performed within 2-3 days
of admission.
3. Statistical AnaIysis.
For nominal data the chi square (X2 ) test was used
to determine whether a significant difference existed
between the observed data in each category and that
expected if there \^¡ere no dif ferences between groups.
Any differences in diagnosis or treatment between
the two years might be accounted for by changes in the
kinds of patients admitted. In particular, the effects
of differences in ag€, sex, previous admission, suicidal
behaviour and d.epression score were considered. In the
chi-square values given for statistical tests of
association, the Mantel-Haenszela sunmary value is given
where adjustment was required. Differences in LPD scores
between'years were analysed by T-test.
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total of 520 case-notes
in 1981. In 1981, l-62
hrere reviewed, 258 in 1980
patients were given the
DST
(a) Variations in case mix.
Historical comparisons are notoriously misleading.
Possible differences in case mix over the two years which
could account for the two periods studied were considered.
In particular, the variables of age, sex, previous
admission, suicidal act and depression score \^rere
considered. It would seem reasonable that variables such
as previous admission, suicidal act and depression score
could be associated with particular treatment and diagnosis;
however, there v¡as no major contribution of these factors
to the variation in treatment and diagnosis over the
period.
It did appear that age and sex variables were of
importance, however. For example, when all patients from
both periods under study were pooled, Several factors with
respect to the age of the patient and treatment and
d.iagnosis became evident.
There was a significant association of antidepressant
drug prescription with increasing age. For example, l-7+
of patients under 30 received antidepressants, while 639
of those over 50 received antidepressants. The number of
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patients treated $rith antidepressants very closely
approximates the number treated with a somatic
antidepressant treatment, as most patients treated with
ECT had a concurrent course of antidepressant medication'
TABLE 3.2



























X2 = 76.L9* df = 2¡ p <.000I-
There was a significant association of diagnosis
of biological depression with increasing age (fable 3.3).
For example, 88 of patients under 30 received this
diagnosis compared with,5tt of patients over 50'
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x2 = 87.43* df = 2¡ P <.0001.
There were significant differences in age d.istribution
between the years (Table 3.4) - For examPle,
patients were aged between 30 and 50 in 1980 '
with 38? in the 1981 Period.
292 of
compared
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X2 = 5.83* df : 2¡ p <.05.
There was a trend towards more frequent d.iagnosis
of biological depression in women than in men (Table 3'5) '
For example, 3Ot of women had this diagnosis compared
with 222 of men.
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TABLE 3.5




















X2 = 3.65 df = 1; P >0.05-
There was a larger proportion of female admissions
in I98O compared with 1981. For example, 338 of the
patient population was male in 1980, compared with 418
in 1981 (Tab1e 3.6).
TABLE 3.6
Variation in sex distribution between years
Sex Year TotaI













x2 = 3.45 df = 1; P >0.05.
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Previous admissions to a psychiatric unit did not
significantly vaiy between the two periods of the study
(Table 3.7) .
TABLE 3.7
Variation in "previous admission"
between 1980 and 1981














x2 = 0.24 df = I¡ n.s.
whether suicidal behaviour occurred did not significantly
vary between the two periods of the study (Table 3.8).
TABLE 3.8
Variation in suicidat behaviour
















x2 = L.2 df = I; n.s
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LPDscoreswereretrievableinonly60sofcases.
The mean depression score which is an index of severity
of depression was IO.7 in I98O and I0'3 in I98I' There
was no significant difference in LPD scores between 1980
and I98I by T test.
There was no significant variation in the disÈribution
of LpD classes between I98O and 1981 (Table 3-9).
TABLE 3.9
Differences in LPD class between years
LPD class Year Total

















x2 = 2.L df = 2¡ n.s.
Note: The LPD emPloYs a decision rule
to allocate Patients to one of
three classes; class ] =
non-endogenous dePressive
syndrome,' class 2 = endogenous
depressive sYndrome; class 3 -
non-depressive sYndrome -
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rn summaryr thenr examination of "case mix" data
from the two periods of the study revealed the following:
Five hundred and twenty case-notes were reviewed,
258 in 1980 and 262 in 1981. Age and sex were found to
be confounding varíabtes. There \^Iere sigmificant
differences ín ager dlst,ribution between the years. There
vras also a significant association of antidepressant d'rug
prescription and diagnosis of biological depression with
increasing age. There was a trend towards more frequent
diagnosis of biological depression in female than in male
patientsr'and there was a larger proportion of female
admissions in t98o than in I98I. Previous admission and
suicidal behaviour did not vary significantly between
years.TherewerenosignificantdifferencesinLPD
scores between years and no significant differences
between LPD classes-
The variation in case-mix between the two years with
respect to age and sex is corrected for in the following
data using the Mantel-Haenszel test. 
q In the following
data chi-square values are given, followed by a corrected
chi-square va1ue, corrected for age and sex' A value of
chi-square of 3.84 indicates significance at the 5t level'
(b) Treatment and diagnostic Practice.
The prescription of antidepressant drugs in the
periods under question in I98O and I98I was examined.
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antidepressants; for example , 36t of patients Iiitere given
antidepressants in 1980, compared with 45t in I9B1' This
trend. becomes more significant when adjustment is made for
the effect of age and sex differences between the years'
TABLE 3.10











x2 3.6 3 df I; corrected x2 = 3.9*; P <0 '05'
Diagnostic practice over the period was examined'
Table 3.1I indicates a trend towards increased diagnosis
of biological depression. For examPle, 23t were diagnosed
as biologically depressed in 1980, compared with 303 in
1981. This cannot be attributed to change in the age and
sex composition of the cases between I9BO and 198I, âs
theeffectsoftheseactedintheoppositedirection.
The trend reaches significance when corrected for age
and sex.
7L
A RETROSPECTIVE STUDY OF THE IMPACT OF THE INTRODUCTION
OF THE DST ON THE D]AGNOSIS AND MANAGEMENT OF PSYCHIATRTC
INPATIENTS:
TABLE 3. 11
Diagnosis of biological depression




















x2 = 3.I2 df = 1; corrected x2 = 4.4*; p <0'05'
(c) Treatment and diaqnosis after the introduction
of the DST.
Diagnostic and treatment practice was further
investigated in the 198I period after the introduction of
the DST. During this period L62 patients, 622' hrere given
the DST. The first question addressed was whether there
was an association between DST result and treatment with
antidepressants in the patients under study. Table 3.12
indicates no association between the result of the DST
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DSfl results and treatment with antidepressants




























X2 = .46 df I; corrected X2 .94¡ n. s
Any association between DST results and diagnosis
was examined. Table 3.13 reveals there was a significant
association between a positive DST result and the
diagnosis of biological depression. Forty-five per cent
of patients with positive DsT results had a diagrnosis
of biotogical depression and 698 with negative DsT results
had other diagnoses.
TABLE 3. 13
DST results and diagnosis of biological depression













x2 = 3.3 df l; corrected X2 5.7*; p <0.05.
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The association between requesting a DST and
treatment and diagnosis was next considered. Table 3.14
shows a strong association between requesting the test
and treatment.
TABLE 3.T4
Requesting DST, or not requesting DST
and treatment












x2 = 16. B* df L¡ p <0.001.
EvenwhenthosewithpositiveDSTresultswere
excludedr âs shown in Table 3.15, this strong association
remained. This association was only a little weakened
by adjustment for age and sex. The data show that 292
of those who did not have the DsT performed had a course
of antidepressants, while 522 of those who had the test
performed but who had a negative result vlere given
antidepressants. There is a significant association,
then, between requeËting the DST and treatment with
antidepressants, even when one excludes those with
I
þ
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positive Dsr results and rooks onry at the group on whom
the DST was performed and had negative results'
TABLE 3.15
DST negative results and DST not requested
associated with treatment

















X2 = 10.4* df t; corrected x2 = 7.I*; P <0'01'
Any association between ordering the DST and the
diagnosis of biological depression was considered'
Nineteen per cent of those who did not have the test
performed were given the diagnosis of biological
depression, while 38S of those who had the test were
given that diagnosis. However' part of this association
maybeattributabletothesignificantassociationbetween
apositiveDSTresultandthediagnosisofbiological
depression. When those with positive DST results were
excluded, âS shown in Table 3.16, there vJas no association
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DST negative results and DST not requested
associated with dilagnosis
Biological dePression Total
x2 = 3.5 df = I¡ corrected x2 = 1.6; n's
In sunmary, the findings from the retrospective
case-note studY were as follows:
t. There was a sigmificant trend towards
increased antidepressant usage over the
two Periods under studY.
2. There was a significant trend towards
increased diagnosis of biological
depression over the periods under study'
3. There \^¡as no association between DST
resultsandtreatmentwithantidepressants.
4. There was a significant association
between DST results and d'iagnosis of
biologicat dePression -
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There was a significant association
between requesting the DST and
antidepressant treatment.
5. Comment.
These findings I^tere surprising. Changes in case
mix between the years under study, with more r^Iomen and
an older population admitted in 1980 compared with 1981,
might suggest that there should have been a greater
proportion of cases of biological depression in 1980.
Just the opposite was observed, with significant trends
towards diagnosis of biological depression and treatment
with antidepressants in the 19BI period. Are there
plausible explanations which could relate these
observations and the other findings of the study to the
introduction of the DST?
Consider a typical career of a patient admitted
to the unit. From clinical experience, on admission,
decisions with regard to the ordering of the DST and to
antidepressant treatment are made very nearly simultaneously.
The patient is gíven the DST and often, antidepressants
may be started at the same time. Some days later the
DST result appears. ft is my experience that once
antidepressant medication has begun, decisions to stop it
on the basis of the DST result are rare. That this should
be So is, of course, quite understandable in terms of the
5
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DSTrs 503 sensitivity for melancholia. unfortunately,
data to test this hypothesis that is, data regarding
changes in medication at the time the DST result became
available - \^¡ere not collected in this study.
On discharge, the diagnosis made by the psychiatric
registrar takes into account the DST result. Thus, it
could be argued, comes about the association between
final diagnosis and DST result. The discharge diagnosis
may also be influenced by the course of management, viz.
antidepressantsi and, in turn, this course of management
is associated with the decision to perform the DST.
Thus a possible explanatorlt model exists. Why the
requesting of the DST should be associated strongly with
antidepressant treatment is unclear. Whether the
psychiatrist's "set" with respect to the nature of
depressive illness is altered by the development of
specific laboratory tests for psychiatric disorders is
one conjecture. As has been commented upon in Chapter
One (p.25) , Mellergard and Leroy have demonstrated the
tendency of clinicians to give an effective treatment'
antidepressant medication, a trial' even when the
information base does not completely support a diagnosis
of endogenous depression. In other words, when a simple,
safe and effective treatment is available for a
potentially lethal condition, the clinician may tend to
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a biological treatment for a psychiatric disorder is
strengthenedbythedevelopmentofabiologicaltestfor
the disorder, then that treatment might be over-prescribed'
particularly if the biological test is only moderately
sensitive.
Mantel and Haenszelq state: "The findings of a
retrospective study are necessarily in the form of
statements about associations between diseases and




observed in the study was caused by the introduction of
the DST. Neither can it be said that the requesting of
the DST was causal in the decision to prescribe
antidepressants. A controlled prospective study could
perhaps address these issues' However' given that the
associations discovered in the retrospective study might
be known to the unit to be prospectively studied' then
obvious difficulties arise' The process of future
clinical judgrment would no doubt be influenced by the
discovery of associations between the introduction of
the DST and changes in diagnosis and t'reatment'
WhiletheDSTmayrallybeliefinanorganicbasis
of some sorts of depression, it is prlzzling that 422 of
patients with positive DST results did not receive a
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trial of antidepressants. Three factors may explain this
finding. Firstly, there may have been a number of patients
who were given the DST before a complete history had
revealed medical conditions or drugs which may have
invalidated the results. secondly, the DST may not be as
specific for biological depression as has been assumed
(see p. 45). Thirdly, it may be that, as has been commented
upon in chapter one-(p. 19), the correlation between
treatment and diagnosis is not high in psychiatry'
whether more notice should be taken of the DST result
is another question, one which could, of course, be only
answered by an outcome studY.
No conclusions regarding causality of the observed
change in diagnostic and treatment patterns can be drawn
from this retrospective study. Factors other than the
introduction of the DST may have affected diagnosis and
treatment. Such factors include changes in admission
policy, changes in patient management philosophy, and
changes in the teaching curriculum of psychiatric
registrars. while there were no known explicit policy
decisions made regarding changes in these areas in the
period of the study, it is possible that such changes did
occur. It is also possible that the changes in management
and treatment observed would have occurred without the
introduction of the DST into the ward, âs staff members
became familiar with the literature surrounding the DST '
Such variables \^Iere not, of course, controtled for, and
as such they reflect a weakness of the study'
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Any retrospective study, of course, has methodological
problems relating to the biases of the study setting and
the question of the representative nature of the cases and
controls under study. In this studyr wê elected not to
match patients before and after the introduction of the
DST for variables such as age or sex. Insteadr \¡l€ elected
to use the summary relative risk formula statistical
technique of Mantel and Haenszel to control for such
factors in our analysis of the data. However, in any
retrospective study an internal examination of the data
raises questions regarding the representative nature of
the data, questions which cannot be completely satisfied
by an internal analysis alone. As suchr âDY associations
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